MARKET

XOMA

XOMA

XOMA Royalty Corporation
NASDAQ
43.00
+0.38
+0.89%
After Hours: 43.00 0 0.00% 16:10 07/02 EDT
OPEN
42.62
PREV CLOSE
42.62
HIGH
43.00
LOW
42.46
VOLUME
137.66K
TURNOVER
--
52 WEEK HIGH
43.00
52 WEEK LOW
22.29
MARKET CAP
760.19M
P/E (TTM)
26.04
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at XOMA last week (0622-0626)?
Weekly Report · 6d ago
Weekly Report: what happened at XOMA last week (0615-0619)?
Weekly Report · 06/22 09:41
Weekly Report: what happened at XOMA last week (0608-0612)?
Weekly Report · 06/15 09:42
XOMA Details Merger Timeline and Preferred Share Redemption
TipRanks · 06/12 23:53
XOMA Corp - 8.375% DP PFD B declares $0.5234 dividend
Seeking Alpha · 06/12 20:31
XOMA Preferred Shares Series A declares $0.539 dividend
Seeking Alpha · 06/12 20:14
Press Release: XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date
Dow Jones · 06/12 20:05
XOMA Royalty Sets July Vote on $39-per-Share Ligand Takeover and Reorganization
TipRanks · 06/10 23:02
More
About XOMA
XOMA Royalty Corporation is a biotechnology royalty aggregator. The Company’s royalty aggregator business is primarily focused on early to mid-stage clinical assets, primarily in Phase I and II, with significant commercial sales potential that are licensed to funded partners. The Company has a portfolio of economic rights and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The Company's commercial assets include OJEMDA (tovorafenib), IXINITY, XACIATO, VABYSMO (faricimab svoa), DSUVIA (sufentanil sublingual tablet), and MIPLYFFA (arimoclomol). Its Phase III assets include Rilvegostomig (AZD2936), Ficlatuzumab (AV-299), Ovaprene, D-Fi (FCX-007), Seralutinib, Cetrelimab (JNJ-63723283), Ersodetug (RZ358), and Mezagitamab (TAK-079). Its Phase II assets include Acimtamig (AFM13), AFM24, Vosaroxin, Aldoxorubicin, G03-52-01, PBF-680, PBF-677, Vidutolimod (CMP-001), and RZ-402. Its others assets include COM902 and MT-0169.

Webull offers XOMA Royalty Corp stock information, including NASDAQ: XOMA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XOMA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XOMA stock methods without spending real money on the virtual paper trading platform.